Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China
· Delayed Price · Currency is CNY 8.34
-0.35 (-4.03%)
Nov 22, 2024, 3:00 PM CST
Tonghua Dongbao Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 341.31 | 1,168 | 1,582 | 1,308 | 929.92 | 811.21 | Upgrade
|
| Depreciation & Amortization | 184.94 | 184.94 | 151.17 | 143.65 | 154.54 | 152.8 | Upgrade
|
| Other Amortization | 0.93 | 0.93 | - | - | 0.12 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | -0.19 | -7.71 | -0.41 | -2.23 | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.13 | 10.13 | 2.04 | 23.04 | 62.47 | 3.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | -92.45 | -92.45 | -930.32 | -296.88 | -39.54 | -40.7 | Upgrade
|
| Provision & Write-off of Bad Debts | 20.12 | 20.12 | -7.41 | 2.26 | 0.9 | 4.83 | Upgrade
|
| Other Operating Activities | 590.45 | 11.93 | -6.65 | 10.31 | 1.64 | 125.89 | Upgrade
|
| Change in Accounts Receivable | -430.93 | -430.93 | 140.57 | -88.27 | 2.33 | -43.14 | Upgrade
|
| Change in Inventory | -55.53 | -55.53 | -124.65 | -3.41 | 97.28 | 269.75 | Upgrade
|
| Change in Accounts Payable | 36.99 | 36.99 | 52.93 | 93.84 | -17.13 | -128.5 | Upgrade
|
| Operating Cash Flow | 613.51 | 861.52 | 863.09 | 1,180 | 1,192 | 1,152 | Upgrade
|
| Operating Cash Flow Growth | 16.30% | -0.18% | -26.88% | -1.00% | 3.48% | 31.39% | Upgrade
|
| Capital Expenditures | -538.99 | -348.13 | -492.88 | -600.75 | -479.59 | -293.13 | Upgrade
|
| Sale of Property, Plant & Equipment | 67.01 | 0.42 | - | 20.37 | 1.28 | 0.02 | Upgrade
|
| Divestitures | - | - | - | - | -22.13 | - | Upgrade
|
| Investment in Securities | -85.5 | 2.5 | 817.06 | 544.82 | -150 | 123 | Upgrade
|
| Other Investing Activities | 35.6 | 23.22 | 19.82 | 23.79 | 33.84 | 17.61 | Upgrade
|
| Investing Cash Flow | -521.89 | -321.99 | 343.99 | -11.76 | -616.61 | -152.5 | Upgrade
|
| Short-Term Debt Issued | - | 190 | - | - | - | 525 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 275 | - | Upgrade
|
| Total Debt Issued | 612.75 | 190 | - | - | 275 | 525 | Upgrade
|
| Short-Term Debt Repaid | - | -40 | - | - | - | -851.31 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -400 | - | Upgrade
|
| Total Debt Repaid | -270 | -40 | - | - | -400 | -851.31 | Upgrade
|
| Net Debt Issued (Repaid) | 342.75 | 150 | - | - | -125 | -326.31 | Upgrade
|
| Common Dividends Paid | -503.13 | -496.25 | -1,096 | -425.04 | -403.58 | -406.8 | Upgrade
|
| Other Financing Activities | -262.29 | 122.29 | -188.28 | -270.56 | 47.79 | -221.09 | Upgrade
|
| Financing Cash Flow | -422.67 | -223.95 | -1,284 | -695.6 | -480.79 | -954.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.91 | 0.57 | 0 | -0 | -0 | 0 | Upgrade
|
| Net Cash Flow | -330.14 | 316.14 | -76.98 | 473.01 | 94.9 | 45.47 | Upgrade
|
| Free Cash Flow | 74.51 | 513.4 | 370.21 | 579.62 | 712.69 | 859.04 | Upgrade
|
| Free Cash Flow Growth | -42.64% | 38.68% | -36.13% | -18.67% | -17.04% | 727.06% | Upgrade
|
| Free Cash Flow Margin | 3.06% | 16.69% | 13.32% | 17.74% | 24.64% | 30.93% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.26 | 0.18 | 0.28 | 0.35 | 0.42 | Upgrade
|
| Cash Interest Paid | 1.66 | 1.66 | - | - | 10.17 | 20.56 | Upgrade
|
| Cash Income Tax Paid | 236.33 | 219.83 | 284.18 | 217.64 | 279.58 | 219.59 | Upgrade
|
| Levered Free Cash Flow | -67.69 | 373.08 | 187.64 | 347.72 | 593.12 | 612.74 | Upgrade
|
| Unlevered Free Cash Flow | -58.97 | 376.31 | 187.81 | 347.72 | 599.48 | 625.59 | Upgrade
|
| Change in Net Working Capital | 37.94 | 238.64 | 55.97 | 21.37 | -205.54 | -176.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.